Evidence map›Paper›PMID 31243109›Full record

ArticleCancer genomics & proteomics

Contribution of Matrix Metalloproteinase-2 Promoter Genotypes to Nasopharyngeal Cancer Susceptibility and Metastasis in Taiwan.

Shih-Wei Hsu, Chi-Li Gong, Huai-Mei Hsu, Chih-Chang Chao, Yun-Chi Wang, Wen-Shin Chang, Yueh-Ting Tsai, Liang-Chun Shih, Chia-Wen Tsai, DA-Tian Bau

Open access · diamondAbstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Analysis ofInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Association ofIn vivo (Athens, Greece)
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shih-Wei HsuGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chi-Li GongDepartment of Physiology, China Medical University, Taichung, Taiwan, R.O.C.
Huai-Mei HsuGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chih-Chang ChaoInstitute of Neurosciences, National Chengchi University, Taipei, Taiwan, R.O.C.
Yun-Chi WangTerry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Wen-Shin ChangTerry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Yueh-Ting TsaiTerry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Liang-Chun ShihGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chia-Wen TsaiTerry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan, R.O.C.
DA-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. datian@mail.cmuh.org.tw artbau2@gmail.com.
China Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimMatrix metalloproteinase 2 (MMP2) is up-regulated in many cancers. However, the association of MMP2 genotype to nasopharyngeal cancer (NPC) susceptibility in Taiwan remains elusive. MATERIALS AND

methodsIn this study, the role of MMP2 promoter C-1306T (rs243865) and C-735T (rs2285053) genotypes were investigated among 208 NPC patients and 416 healthy controls, and their role in NPC staging and TNM classifications were examined.

resultsThere was no differential distribution as for the genotypic or allelic frequencies at MMP2 promoter C-1306T or C-735T between the control and case groups. Noticeably, those with MMP2 C-1306T CT+TT genotypes had a lower metastatic risk than those with CC (p=0.0295). As for staging, T and N classifications, there was no differential distribution in C-1306T genotypes (p>0.05). Also, there was no differential distribution of C-735T genotypes according to different behavioral/clinicopathological characteristics.

conclusionCT and TT genotypes at MMP2 C-1306T were associated with a significantly decreased risk of NPC metastasis.

Indexed as

FemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMatrix Metalloproteinase 2Nasopharyngeal CarcinomaNeoplasm MetastasisTaiwanMatrix Metalloproteinase 2GenotypemetastasisMMP2nasopharyngeal cancerpolymorphismsusceptibilityTaiwan

Identifiers

PMID31243109
PMCPMC6609263
OpenAlexW2954240875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.